Accretion Nutraveda Ipo
Accretion Nutraveda IPO Review & Key Points
Review: Neutral
IPO Lead Managers aka Merchant Bankers
Sobhagya Capital Options Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ₹2,58,000 |
| Retail Maximum | 2 | 2,000 | ₹2,58,000 |
| S-HNI Minimum | 3 | 3,000 | ₹3,87,000 |
| S-HNI Maximum | 7 | 7,000 | ₹9,03,000 |
| B-HNI Minimum | 8 | 8,000 | ₹10,32,000 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 5,46,000 Shares | 28.44% |
| QIB (Ex. Anchor) | 3,62,000 Shares | 18.85% |
| NII Shares Offered | 2,76,000 Shares | 14.37% |
| Retail Shares Offered | 6,40,000 Shares | 33.33% |
| Anchor Bidding Date | January 27, 2026 |
| Anchor Investors List | |
| Shares Offered | 5,46,000 Shares |
| Anchor Size | 7.04 Cr. |
| lock-in period end date 50% shares (30 Days) | March 4, 2026 |
| lock-in period end date 50% shares (90 Days) | May 3, 2026 |
| IPO Open Date: | January 28, 2026 |
| IPO Close Date: | January 30, 2026 |
| Basis of Allotment: | February 2, 2026 |
| Refunds: | February 3, 2026 |
| Credit to Demat Account: | February 3, 2026 |
| IPO Listing Date: | February 4, 2026 |
| IPO Bidding Cut-off Time: | January 30, 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 53,20,000 | 100% |
| Promoter Holding Post Issue | 72,40,000 | 73.48% |
| Purpose | Crores |
| Purchase of Machineries for Automation in existing Manufacturing unit | ₹4.22 |
| Purchase of Machineries for New Manufacturing Setup | ₹8.03 |
| Funding working capital requirements of our company | ₹5.50 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹3.07 | ₹2.78 | ₹0.28 | ₹4.06 |
| 2024 | ₹5.20 | ₹4.28 | ₹0.82 | ₹4.64 |
| 2025 | ₹16.06 | ₹12.87 | ₹2.61 | ₹10.86 |
| Sep 2025 | ₹14.07 | ₹11.20 | ₹2.33 | ₹16.35 |
| KPI | Values |
| ROE: | 81.22% |
| ROCE: | 36.98% |
| EBITDA Margin: | 22.79% |
| PAT Margin: | 16.33% |
| Debt to equity ratio: | – |
| Earning Per Share (EPS): | ₹7.19 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 48.85% |
| Net Asset Value (NAV): | ₹14.72 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Walpar Nutritions Ltd. | 1.80 | 23.94 | 11.27% | 13.65 | 60.26 Cr. |
| Influx Healthtech Limited | 7.31 | 25.93 | 36.72% | 5.31 | 104.99 Cr. |
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| IPO Open Date | January 28, 2026 |
| IPO Close Date | January 30, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹122 to ₹129 Per Share |
| Issue Size | Approx ₹24.77 Crores |
| Fresh Issue | Approx ₹24.77 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |